Clinical Trials Browser

Not yet recruiting × OTHER × Breast Neoplasms × Clear all

NCT06148038 2026-03-18

CBD for Breast Cancer Primary Tumors

Phase 1 Not yet recruiting

Breast Neoplasms

NCT07475923 2026-03-17

Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)

Not yet recruiting

Breast Neoplasms

NCT07478315 2026-03-17

IMPOWER-QoL: IMPact Of Discontinuing Premedication for WEekly Paclitaxel on bReast Cancer Patient's Quality Of Life

Phase NA Not yet recruiting

Breast Neoplasms, Hypersensitivity

NCT07478718 2026-03-17

Shoulder Exercise Training on Pain, Range of Motion, and Functional Limitations in Women Following Unilateral Mastectomy

Phase NA Not yet recruiting

Breast Neoplasms

NCT07474090 2026-03-16

STEPS-BC

Phase NA Not yet recruiting

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT07475325 2026-03-16

E-C-HAU

Not yet recruiting

Breast Neoplasms

NCT07257484 2026-03-13

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

Phase 4 Not yet recruiting

Breast Neoplasms, Obesity

NCT07447700 2026-03-12

A Pilot Study to Evaluate the Effectiveness of Focused Massage on Pain, Mobility, and Quality of Life During Radiation Treatment for Patients With Breast Cancer

Phase NA Not yet recruiting

Breast Neoplasms

NCT07466303 2026-03-12

Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for Triple-Negative Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07467824 2026-03-12

PREACT

Phase NA Not yet recruiting

Breast Neoplasms, Motor Activity

NCT07455955 2026-03-11

Personalized Antiemetic Regimen According to Patients' Pharmacogenetic Profile

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07465172 2026-03-11

GRADE

Phase NA Not yet recruiting

Breast Neoplasms, Nausea, Vomiting, Weight Loss

NCT07447414 2026-03-09

LUBRECA

Phase NA Not yet recruiting

Breast Neoplasms

NCT07300995 2026-03-06

Behavioral Pain Intervention for Older Cancer Patients

Phase NA Not yet recruiting

Breast Neoplasms, Neoplasms, Pain

NCT07454668 2026-03-06

Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases

Phase 1 Not yet recruiting

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT07428018 2026-03-05

VIOLET

Phase 2 Not yet recruiting

Breast Neoplasms

NCT06251544 2026-03-04

TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer

Phase 1 Not yet recruiting

Breast Neoplasms, Mammary Neoplasms, Animal

NCT07449273 2026-03-04

BREATH-RCT

Phase NA Not yet recruiting

Anxiety Disorders, Breast Neoplasms, Pain, Postoperative

NCT07276880 2026-03-03

P-RAD(+)TN-DCT

Phase 2 Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07446686 2026-03-03

Study on the Safety and Tolerability of Postoperative Radiotherapy Concurrent With CDK4/6 Inhibitors in HR+/HER2- High-Risk Breast Cancer

Phase EARLY_PHASE1 Not yet recruiting

Breast Neoplasms

NCT07441486 2026-03-02

A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and Oral Paclitaxel in the Treatment of HR+HER2- Advanced Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07441889 2026-03-02

HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)

Phase 1/2 Not yet recruiting

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT07443774 2026-03-02

AdheRA

Not yet recruiting

Breast Neoplasms

NCT07109817 2026-02-27

DETOXp

Phase 2 Not yet recruiting

Breast Neoplasms, Peripheral Nervous System Diseases

NCT07436663 2026-02-27

SGLT2i/DPPi

Phase 4 Not yet recruiting

Breast Neoplasms

NCT07437326 2026-02-27

QVA-Mod

Not yet recruiting

BreastGastrointestinalHead & NeckThoracic

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Neoplasms

NCT07406087 2026-02-25

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

Phase NA Not yet recruiting

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcoma

Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Testicular Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT07432178 2026-02-25

CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer（Cinnamon）

Phase 3 Not yet recruiting

Breast Neoplasms

NCT07418060 2026-02-24

PREHAB KINELGD

Phase NA Not yet recruiting

Breast Neoplasms

NCT07429487 2026-02-24

WATCH AND ACT

Phase NA Not yet recruiting

BreastGastrointestinal

Breast Neoplasms, Fatigue, Pancreatic Neoplasms, Colorectal Neoplasms

NCT07425548 2026-02-23

JOUVENCE

Phase NA Not yet recruiting

Breast Neoplasms

NCT07426913 2026-02-23

Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab

Phase NA Not yet recruiting

Breast Neoplasms

NCT06958224 2026-02-20

ESCAT

Phase NA Not yet recruiting

BreastGastrointestinal

Breast Neoplasms, Liver Neoplasms

NCT07394946 2026-02-20

NELOPHER

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07423611 2026-02-20

RACE

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07197684 2026-02-19

Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer Surgery

Phase NA Not yet recruiting

Breast Neoplasms, Pain, Postoperative, Chronic Pain

NCT07419711 2026-02-19

Grape Polyphenols for Prevention of Chemotherapy-Induced Cardiotoxicity

Phase NA Not yet recruiting

Breast Neoplasms

NCT07419867 2026-02-19

A Platform Study Based on Specific Tracer for Evaluating the Therapeutic Efficacy of Systemic Treatment for Breast Cancer Using PET/MRI

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07319195 2026-02-18

WINIT-BC

Phase EARLY_PHASE1 Not yet recruiting

Breast Neoplasms

NCT07410559 2026-02-18

Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07417241 2026-02-18

SHR-A1811 vs Pyrotinib/Capecitabine in Trastuzumab-Resistant HER2+ Advanced Breast Cancer: A Randomized Study

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07217990 2026-02-17

NoCUT-BC

Phase 1/2 Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07411651 2026-02-17

EXPOSAL

Phase NA Not yet recruiting

Breast Neoplasms

NCT07415200 2026-02-17

LAF-ALND

Phase NA Not yet recruiting

Breast Cancer Lymphedema, Breast Neoplasms, Postoperative Complications

NCT07285993 2026-02-13

Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET

Phase 2 Not yet recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT07409948 2026-02-13

AIMSS-CARE

Phase NA Not yet recruiting

Treatment Adherence and Compliance, Breast Neoplasms, Fatigue, Motor Activity, Musculoskeletal Diseases, Pain, Fatigue Syndrome, Chronic, Arthralgia, Musculoskeletal Pain

NCT07398118 2026-02-12

CRYO-1

Phase NA Not yet recruiting

Breast Neoplasms

NCT07406594 2026-02-12

MICRO-VERZ

Phase NA Not yet recruiting

Breast Neoplasms

NCT07406789 2026-02-12

LUMInova

Phase 2 Not yet recruiting

Breast Neoplasms, Neoplasms

NCT07407517 2026-02-12

POLARIS

Phase 3 Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms